Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | GAA | P10253 | 2/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.85 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.85 |
| ▸ | TTR | P02766 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | PDE4A | P27815 | 1/20 | 0.39 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1176879 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL59830 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11554769 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL27350 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11584070 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL11559655 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL25148109 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| Morpholine SCHEMBL8649532 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL111814 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 | |
| SCHEMBL897208 | 1.00 | MEN1 (1.00) | MEN1KMT2AGAAKDM4ECYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240128509-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2024-04-18 | — | — | US | claimed |
| CN-117203815-A | Electrolyte for rechargeable lithium battery and rechargeable lithium battery including the same | 三星SDI株式会社 | 2023-12-08 | — | — | CN | claimed |
| EP-4239747-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | Samsung SDI Co., Ltd. (KR) | 2023-09-06 | — | — | EP | claimed |
| WO-2023140429-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-07-27 | — | — | WO | claimed |
| US-20200190135-A1 | LASSO STRUCTURES AND THEIR SYNTHESIS | CHROMACON AG (CH) | 2020-06-18 | — | — | US | claimed |
| EP-3541828-A1 | LASSO STRUCTURES AND THEIR SYNTHESIS | ChromaCon AG (CH) | 2019-09-25 | — | — | EP | claimed |
| WO-2018091339-A1 | LASSO STRUCTURES AND THEIR SYNTHESIS | CHROMACON AG (CH) | 2018-05-24 | — | — | WO | claimed |
| US-20240128509-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2024-04-18 | — | — | US | disclosed |
| CN-117203815-A | Electrolyte for rechargeable lithium battery and rechargeable lithium battery including the same | 三星SDI株式会社 | 2023-12-08 | — | — | CN | disclosed |
| EP-4239747-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | Samsung SDI Co., Ltd. (KR) | 2023-09-06 | — | — | EP | disclosed |
| WO-2023140429-A1 | ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME | 삼성에스디아이 주식회사 | 2023-07-27 | — | — | WO | disclosed |
| US-20220193249-A1 | Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring | POLYTHERICS LIMITED (GB) | 2022-06-23 | — | — | US | disclosed |
| EP-3512856-B1 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | POLYTHERICS LTD (GB) | 2021-03-24 | — | — | EP | disclosed |
| EP-3541828-A1 | LASSO STRUCTURES AND THEIR SYNTHESIS | ChromaCon AG (CH) | 2019-09-25 | — | — | EP | disclosed |
| US-20190202839-A1 | Novel Cytotoxic Agents And Conjugates Thereof | ABZENA (CAMBRIDGE) LIMITED (GB) | 2019-07-04 | — | — | US | disclosed |
| WO-2018091339-A1 | LASSO STRUCTURES AND THEIR SYNTHESIS | CHROMACON AG (CH) | 2018-05-24 | — | — | WO | disclosed |
| WO-2018051109-A1 | NOVEL CYTOTOXIC AGENTS AND CONJUGATES THEREOF | POLYTHERICS LIMITED (GB) | 2018-03-22 | — | — | WO | disclosed |
| WO-2017178828-A1 | CONJUGATES AND CONJUGATING REAGENTS COMPRISING A LINKER THAT INCLUDES AT LEAST TWO (-CH2-CH2-0-) UNITS IN A RING | POLYTHERICS LIMITED (GB) | 2017-10-19 | — | — | WO | disclosed |
| US-20170051084-A1 | FILTERING MATERIAL, FILTRATION FILTER, AND FILTRATION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-02-23 | — | — | US | disclosed |
| US-6323163-B1 | PERFLUOROPOLYOXYALKYLENE CHAIN HAVING AVERAGE MOLECULAR WEIGHT OF 800 OR MORE, CONTAINING CYCLIC POLYETHER GROUP HAVING AT LEAST 4 OXYGEN ATOMS, ALSO HAVING AMIDE, SULFONAMIDE, ETHER OR ESTER LINKAGE BETWEEN CHAIN AND CYCLIC GROUP | HITACHI, LTD. (JP) | 2001-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190202839-A1 | Novel Cytotoxic Agents And Conjugates Thereof | CD2BP2, DDB1, DCLRE1A | MEN1 3229/4885KMT2A 4425/4885GAA 1526/4885 |
| US-20220193249-A1 | Conjugates And Conjugating Reagents Comprising A Linker That Includes At Least Two (-CH2-CH2-O-) Units In A Ring | BCR, CD2BP2, LANCL1 | MEN1 558/4885KMT2A 942/4885GAA 4018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.